TOP AGO TUMOR SECRETS

In the next, these subjects are explained in the context of the leading procedures in adjuvant therapy of EBC.There have been no clinically related improvements in comparison with 2011 except for new facts and new tips with regard to the treatment method with bisphosphonates and denosumab (see portion ‘Bisphosphonates and RANKL Antibody Denosumab